EC

Elmind Capital Portfolio holdings

AUM $339M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$339M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1 +$32.9M
2 +$32.4M
3 +$23.5M
4
CLDX icon
Celldex Therapeutics
CLDX
+$22.8M
5
CGON icon
CG Oncology
CGON
+$20.4M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
1
Cogent Biosciences
COGT
$6.49B
$41.6M 12.27%
+1,170,740
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.8B
$39M 11.5%
+1,855,000
VRDN icon
3
Viridian Therapeutics
VRDN
$2.76B
$26.7M 7.89%
+858,631
VERA icon
4
Vera Therapeutics
VERA
$2.96B
$24.4M 7.21%
+482,500
CLDX icon
5
Celldex Therapeutics
CLDX
$2.05B
$23.5M 6.93%
+865,000
CGON icon
6
CG Oncology
CGON
$4.71B
$20.4M 6.03%
+492,500
BCRX icon
7
BioCryst Pharmaceuticals
BCRX
$1.87B
$16.8M 4.95%
+2,150,000
PCVX icon
8
Vaxcyte
PCVX
$9.05B
$13.4M 3.97%
+291,500
BEAM icon
9
Beam Therapeutics
BEAM
$3B
$13.2M 3.9%
+476,338
PHVS icon
10
Pharvaris
PHVS
$1.79B
$13.2M 3.9%
+475,750
KALV icon
11
KalVista Pharmaceuticals
KALV
$797M
$12.9M 3.82%
+801,300
DVAX
12
DELISTED
Dynavax Technologies
DVAX
$10.5M 3.09%
+679,900
TYRA icon
13
Tyra Biosciences
TYRA
$1.84B
$9.2M 2.72%
+350,000
NRIX icon
14
Nurix Therapeutics
NRIX
$1.62B
$8.73M 2.58%
+460,000
WVE icon
15
Wave Life Sciences
WVE
$2.7B
$7.61M 2.25%
+447,846
MBX
16
MBX Biosciences
MBX
$1.6B
$6.65M 1.96%
+211,000
KRYS icon
17
Krystal Biotech
KRYS
$7.97B
$5.42M 1.6%
+22,000
UTHR icon
18
United Therapeutics
UTHR
$23B
$5.36M 1.58%
+11,000
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$11.8B
$4.87M 1.44%
+82,000
RLAY icon
20
Relay Therapeutics
RLAY
$1.6B
$4.54M 1.34%
+536,946
TVTX icon
21
Travere Therapeutics
TVTX
$2.63B
$4.2M 1.24%
+110,000
PTGX icon
22
Protagonist Therapeutics
PTGX
$5.45B
$3.32M 0.98%
+38,000
CGEM icon
23
Cullinan Oncology
CGEM
$848M
$3.21M 0.95%
+310,000
LQDA icon
24
Liquidia Corp
LQDA
$2.61B
$3.1M 0.92%
+90,000
CTMX icon
25
CytomX Therapeutics
CTMX
$979M
$2.98M 0.88%
+700,000